Aurobindo Pharma to buy back 5.4 mln shr at INR 1,475/shr, record date Apr 17
This story was originally published at 10:14 IST on 6 April 2026
Register to read our real-time news.Informist, Monday, Apr. 6, 2026
--Aurobindo Pharma to buy back 5.4 mln shares at INR 1,475 per share
--Aurobindo Pharma to buy back shares worth INR 8 bln; record date is Apr 17
MUMBAI – Aurobindo Pharma Ltd. Monday said it will buy back 5.4 million shares of the company at INR 1,475 per share, which is nearly 11% premium to the stock's closing price on Thursday. It will buy back shares worth INR 8 billion and the record date to decide the eligible shareholders is set at Apr. 17.
All equity shareholders and beneficial owners of the company will be involved in the buyback, Aurobindo Pharma said in an exchange filing. As on Dec. 31, promoters and promoter groups held 51.82% stake in the company, Aurobindo Pharma said.
For the December quarter, the company reported consolidated net profit of INR 9.10 billion and revenue of INR 86.46 billion. At 1000 IST, shares of Aurobindo Pharma traded at INR 1,328.40, down 0.3% on the National Stock Exchange. End
IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT
Reported by Ruchira Kagita
Edited by Akul Nishant Akhoury
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2026. All rights reserved.
To read more please subscribe
